| 摘要 |
<p>BPH in human males, unstable bladder contractions in human females, and LUTS in both males and females can be treated by orally administering an effective amount of a cGMP PDE inhibitor to a patient in need of such treatment. The cGMP PDE inhibitor can be co-administered with an alpha -adrenergic antagonist. When a combination of a cGMP PDE inhibitor and an alpha -adrenergic antagonist are administered, they can be administered together in a composition or administered separately. If administered separately, they can be embodied in a kit.</p> |
